Bionano Genomics (BNGO) Other Accumulated Expenses (2024 - 2026)

Bionano Genomics has disclosed Other Accumulated Expenses across 3 years of filings, most recently posting $458000.0 for Q1 2026.

• Other Accumulated Expenses for Q1 2026 came in at $458000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $458000.0 (changed N/A YoY), and the FY2025 annual result was $499000.0, up 3018.75% from the prior year.
• Other Accumulated Expenses came in at $458000.0 for Q1 2026 at Bionano Genomics, down from $499000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $499000.0 in Q4 2025 to a low of $16000.0 in Q4 2024.
• The 3-year median for Other Accumulated Expenses is $458000.0 (2026), against an average of $324333.3.
• Peak annual rise in Other Accumulated Expenses reached 3018.75% in 2025, while the deepest fall reached 3018.75% in 2025.
• Bionano Genomics' Other Accumulated Expenses stood at $16000.0 in 2024, then soared by 3018.75% to $499000.0 in 2025, then decreased by 8.22% to $458000.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $458000.0 (Q1 2026), $499000.0 (Q4 2025), and $16000.0 (Q4 2024), per Business Quant data.